Discovery Tools (Healthcare) · San Francisco, CA · Founded 2012 · Privately Held (backing)
Developer of a bench-top primary cell control system designed to advance immunotherapy research and manufacturing, empowering scientists with better tools for cell maintenance, expansion, and control. Xcell Biosciences is based in San Francisco, CA and was founded in 2012. Its last reported valuation was $65.5 million in Sep 2021. It has raised $60.4 million across 3 recorded rounds; the latest was a $27.5 million later-stage round in Dec 2024.
Last reported valuation
$65.5M
Oct 2026
Priced at
—
Total raised
$60.4M
Last round
Later Stage VC
Dec 2024
Cap table — not yet on record
Xcell Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Xcell Biosciences with a free account
·The complete investor list: 21 names
·Watch Xcell Biosciences: the Monday email on marks, rounds and moves
Where does Xcell Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Xcell Biosciences's 3 recorded funding rounds.
